Eclipse's PACIFIC Trial Suggests Improved Outcomes For PTMR Patients
This article was originally published in The Gray Sheet
Executive Summary
Eclipse Surgical's PACIFIC trial evaluating percutaneous transmyocardial revascularization (PTMR) for refractory angina shows a significant increase in patients' exercise tolerance, but leaves open the question of whether or not they experience a placebo effect from the procedure.You may also be interested in...
Eclipse Axcis PTMR Clinical Data Could Bring Approval In September
Eclipse Axcis PTMR Clinical Data Could Bring Approval In September
Laser Myocardial Therapies Under The Beam In Light Of J&J DIRECT Results
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: